Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Longer treatment with EMLA associated with increased pain relief during cleansing of leg ulcers

July 27, 1998

Boehringer Ingelheim reports preliminary findings of ECASS II trial

July 27, 1998

Phosphonic acids that block EAA receptors: new series from Novartis

July 27, 1998

ALX-0646 development accelerated

July 24, 1998

Neuroprotective agents disclosed by Shionogi

July 24, 1998

Natural glutamate uptake inhibitors useful for memory disturbances

July 24, 1998

Beta-sheet breaker peptide potentially effective against amyloidosis in Alzheimer's disease

July 24, 1998

Genentech stroke study terminated due to inability to demonstrate clinical benefit

July 23, 1998

Zelapar receives approval recommendation in U.K.

July 23, 1998

Phase III clinical trial results with galantamine suggest novel mechanism of action

July 23, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...